http://www.anaptysbio.com/News/id/13/ 21 Jan 2010 23:17:00 GMT “The potential of the [SHM platform] to provide medical differentiation is what is important.” Eric de la Fortelle, Roche http://www.anaptysbio.com/News/id/13/news_id/6/ 21 Jan 2010 23:17:00 GMT http://www.anaptysbio.com/News/id/13/news_id/6/ Founded in 2005 and located in San Diego (USA), AnaptysBio uses somatic hypermutation (SHM) for antibody discovery and optimization. http://www.anaptysbio.com/News/id/13/news_id/5/ 8 May 2009 14:31:00 GMT http://www.anaptysbio.com/News/id/13/news_id/5/